mRNA ELECTROSHOCK TO PHARMAS
21/08/26 -"Moderna’s mRNA cancer vaccine combined with Merck’s Keytruda does look like a game changer for the wider pharma industry. It looks like a decisive breakthrough, meeting formidable demand. It is not ..."
Pages
63
Language
English
Published on
21/08/26
You may also be interested by these reports :
21/08/26
In our previous paper on Handelsbanken (SELL; Sweden), we pointed out that the bank was suffering from its “Swedishness”, with the bank’s dependence ...
12/08/26
ABN delivered a strong, high-quality Q2, beating consensus by 5% on revenue across NII, fees and costs, with RoE at 12.1%. FY26 NII (c. €6.6bn) and ...
10/08/26
The recent turmoil in EFG International’s (ADD, Switzerland) share price stems from concerns regarding the bank’s ability to keep its margins under ...
07/08/26
As announced in our post-release comments, we have made only minor changes to our forecasts. This has had a limited impact on the overall valuation. ...